Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

BDX stock hub

Becton, Dickinson and Company has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BDXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

41.2B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

BDX

In the news

Latest news · BDX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.3

P25 12.3P50 18.4P75 33.1

Trailing P/E25.9

P25 14.9P50 23.2P75 38.5

ROE6.7

P25 -105.6P50 -46.5P75 -3.1

ROIC7.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BDX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

279

Groups with data

Currency

USD

Showing 279 of 279 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000010795
Company name	Becton, Dickinson and Company
Country	United States
Country code	US
Cusip	075887109
Employees	72,000
Employees Change	-2,000%
Employees Change Percent	-2.7
Enterprise value	$57.6B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Instruments & Supplies
IPO Date	1962-04-23
Isin	US0758871091
Last refreshed	2026-05-10
Market cap	$41.2B
Market cap category	Large-Cap
Price	$149
Price currency	USD
Rev Per Employee	308,708.33x
Sector	Healthcare
Sic	3841
Symbol	BDX
Website	https://www.bd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.77%
EV Earnings	50.6x
EV Sales Forward	2.94x
EV/EBIT	15.61x
EV/EBITDA	9.36x
EV/FCF	18.87x
EV/Sales	2.59x
FCF yield	7.42%
Forward P/E	11.29x
P/B ratio	1.71x
P/E ratio	25.94x
P/S ratio	1.85x
PE Ratio10 Y	65.11x
PE Ratio3 Y	43.06x
PE Ratio5 Y	42.37x
PEG ratio	3.87x
PS Forward	2.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.61%
EBITDA Margin	27.7%
FCF margin	13.74%
Gross margin	47.09%
Gross Profit	$10.5B
Gross Profit Growth	19.02%
Gross Profit Growth Q	6.48%
Gross Profit Growth3 Y	6.78%
Gross Profit Growth5 Y	4.26%
Net Income	$1.1B
Net Income Growth	-23.97%
Net Income Growth Years	0%
Net Income Growth3 Y	-9.31%
Net Income Growth5 Y	-7.02%
Pretax Margin	8.52%
Profit Margin	5.12%
Profit Per Employee	$15,819
Profitable Years	34
ROA	4.38
Roa5y	3.22
ROCE	8.72
ROE	6.67
Roe5y	6.51
ROIC	7.59
Roic5y	6.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.26%
Cagr15y	7.38%
Cagr1y	16.45%
Cagr20y	7.64%
Cagr3y	-7.45%
Cagr5y	-2.4%
Div CAGR10	4.97%
Div CAGR3	5.19%
Div CAGR5	5.02%
EPS Growth	-22.78
EPS Growth Years	0
EPS Growth3 Y	-9.27
EPS Growth5 Y	-6.63
FCF Growth	17.19%
FCF Growth3 Y	44.65%
FCF Growth5 Y	-5.95%
OCF Growth	16%
OCF Growth10 Y	5.52%
OCF Growth3 Y	24.87%
OCF Growth5 Y	-5.44%
Revenue Growth	15.53x
Revenue Growth Q	5.22x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	5.72x
Revenue Growth5 Y	3.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$50.8B
Cash	$816M
Current Assets	$8B
Current Liabilities	$8.5B
Debt	$17.3B
Debt EBITDA	$2.72
Debt Equity	$0.72
Debt FCF	$5.66
Equity	$24.1B
Interest Coverage	6.05
Liabilities	$26.7B
Long Term Assets	$42.8B
Long Term Liabilities	$18.2B
Net Cash	$-16.5B
Net Cash By Market Cap	$-39.98
Net Debt EBITDA	$2.67
Net Debt Equity	$0.68
Net Debt FCF	$5.39
Tangible Book Value	$-10.2B
Tangible Book Value Per Share	$-36.91
WACC	5.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.94
Inventory Turnover	3.32
Net Working Capital	$1.3B
Quick ratio	0.36
Working Capital	$-495M
Working Capital Turnover	$92.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.3%
Dividend Growth	2.95%
Dividend Growth Years	54%
Dividend per share	$4.2
Dividend Years	56
Dividend Yield	2.81%
Ex Div Date	2026-06-09
Last Dividend	$1.05
Payout Frequency	Quarterly
Payout Ratio	105.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	37.8%
1Y total return	16.44%
200-day SMA	182.8
3Y total return	-20.74%
50-day SMA	157.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-11.43%
All Time High	287.3
All Time High Change	-47.99%
All Time High Date	2023-07-24
All Time Low	1.27
All Time Low Change	11,638.41%
All Time Low Date	1974-08-19
ATR	4.32
Beta	0.29
Beta1y	1.03
Beta2y	0.48
Ch YTD	-23
High	155.3
High52	213.1
High52 Date	2026-02-04
High52ch	-29.87%
Low	146.5
Low52	143
Low52 Date	2026-05-05
Low52ch	4.5%
Ma50ch	-4.94%
Premarket Change Percent	0.19
Premarket Price	$154
Premarket Volume	66,110
Price vs 200-day SMA	-18.25%
RSI	44.2
RSI Monthly	32.59
RSI Weekly	32.34
Sharpe ratio	0.58x
Sortino ratio	1.3
Total Return	4.11%
Tr YTD	-1.39
Tr15y	190.83%
Tr1m	-3.57%
Tr1w	0.08%
Tr3m	-8.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	1
Analyst Price Target Top	$215
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$2.77
Earnings EPS Estimate Growth	-0.72
Earnings Revenue Estimate	4,671,415,968x
Earnings Revenue Estimate Growth	4.27x
Operating Income	$3.7B
Operating Income Growth	33.33
Operating Income Growth Q	3.12
Operating Income Growth3 Y	13.26
Operating Income Growth5 Y	4.53
Operating margin	16.61
Price target	$185
Price Target Change	$23.5
Price Target Change Top	$43.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	274,782,938%
Float Percent	99.73%
Net Borrowing	-2,471,000,000
Shares Insiders	0.15%
Shares Institutions	99.24%
Shares Out	275,540,427
Shares Qo Q	-2.77%
Shares Yo Y	-1.3%
Short Float	2.63%
Short Ratio	3.06
Short Shares	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.8B
Average Volume	3,165,834.7x
Bv Per Share	87.58
CAPEX	$-774M
Ch10y	-9.35
Ch15y	72.91
Ch1m	-3.57
Ch1w	0.08
Ch1y	-10.6
Ch20y	138.6
Ch3m	-28.85
Ch3y	-41.09
Ch5y	-37.58
Ch6m	-15.98
Change	-2.5%
Change From Open	-2.89
Close	153.3
Days Gap	0.4
Depreciation Amortization	2,465,000,000
Dollar Volume	669,694,752.7
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$3.7B
EBITDA	$6.2B
EPS	$3.99
F Score	7
FCF	$3.1B
FCF EV Yield	5.3x
FCF Per Share	$11.08
Financing CF	-2,293,000,000
Fiscal Year End	September
Founded	1,897
Goodwill	25,955,000,000
Graham Number	88.62092
Graham Upside	-40.69
Income Tax	$246M
Investing CF	-1,205,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	1998-08-21
Last Split Type	Forward
Last10k Filing Date	2025-11-25
Lynch Fair Value	$19.93
Lynch Upside	-86.66
Ma150	180.8
Ma150ch	-17.36%
Ma20	152
Ma20ch	-1.67%
Net CF	344,000,000
Next Earnings Date	2026-08-06
Open	153.9
Optionable	Yes
P FCF Ratio	13.48
P OCF Ratio	10.76
Payment Date	2026-06-30
Position In Range	33.45
Post Close	149.4
Postmarket Change Percent	-0.1
Postmarket Price	$149
Ppne	6,082,000,000
Pre Close	153.3
Price Date	2026-05-08
Price EBITDA	$6.69
Relative Volume	1.42x
Revenue	22,227,000,000x
SBC By Revenue	1.24x
Share Based Comp	276,000,000
Tax By Revenue	1.11x
Tax Rate	13%
Tr20y	336.26%
Tr6m	8.19%
Us State	New Jersey
Volume	4,481,662
Z Score	2.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BDX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.8%

$4.20 annual per share

Payout ratio

+105.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.0%

54 consecutive years of growth

Total shareholder yield

+4.1%

Next ex-dividend date: 2026-06-09

Performance

BDX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BDX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.2%

Float: +99.7% of shares outstanding

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BDX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.2

Neutral momentum band

Price vs 200-day MA

-18.2%

50/200-day relationship not available

Beta (5Y)

0.29

Less volatile than the market

Sharpe ratio

0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BDX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BDX stock rating?

Becton, Dickinson and Company is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BDX analysis?

The full report lives at /stocks/BDX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BDX?

The latest report frames BDX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BDX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.